{"abortion spontaneous": 3.81, "abscess": 2.66, "agranulocytosis": 2.77, "alopecia": 3.81, "anal incontinence": 2.29, "ataxia": 2.18, "b-lymphocyte count decreased": 378.89, "balance disorder": 3.27, "basal cell carcinoma": 4.88, "bladder disorder": 3.56, "blindness unilateral": 2.06, "blood immunoglobulin g decreased": 100.84, "blood immunoglobulin m decreased": 176.23, "breast cancer": 3.94, "bronchitis": 2.17, "cd19 lymphocytes decreased": 214.23, "cellulitis": 2.37, "central nervous system lesion": 6.62, "cervix carcinoma": 2.91, "cognitive disorder": 3.18, "colitis": 5.55, "colitis microscopic": 9.92, "coronavirus infection": 9.18, "covid-19": 3.02, "covid-19 pneumonia": 18.96, "crohn's disease": 2.62, "cystitis": 7.82, "decubitus ulcer": 4.49, "disability": 4.71, "ear infection": 2.58, "ear pruritus": 17.24, "encephalitis": 3.04, "expanded disability status scale score increased": 99.34, "fall": 2.45, "flushing": 2.43, "fungal infection": 2.7, "gait disturbance": 4.52, "genital herpes": 10.76, "gingivitis": 4.91, "hemiparesis": 5.17, "herpes virus infection": 9.65, "herpes zoster": 2.42, "hypogammaglobulinaemia": 30.17, "ill-defined disorder": 2.21, "immunodeficiency": 8.86, "immunoglobulins decreased": 66.18, "immunosuppression": 9.67, "infection": 3.24, "infusion related reaction": 32.76, "intentional product use issue": 3.59, "intervertebral disc protrusion": 2.83, "intraductal proliferative breast lesion": 16.31, "invasive ductal breast carcinoma": 11.13, "jc polyomavirus test positive": 273.48, "localised infection": 2.17, "lymphocyte count decreased": 11.04, "lymphopenia": 21.07, "magnetic resoce imaging abnormal": 47.64, "magnetic resoce imaging head abnormal": 15.15, "magnetic resoce imaging spinal abnormal": 192.96, "maligt melanoma": 6.84, "maternal exposure before pregcy": 26.95, "maternal exposure during pregcy": 2.12, "maternal exposure timing unspecified": 7.7, "memory impairment": 2.2, "meningitis": 3.59, "meningitis aseptic": 2.58, "multiple sclerosis": 73.3, "multiple sclerosis pseudo relapse": 124.27, "multiple sclerosis relapse": 81.75, "muscle spasticity": 25.42, "muscular weakness": 2.43, "nasopharyngitis": 2.14, "neoplasm": 3.01, "neuralgia": 2.04, "neutropenia": 2.73, "no adverse event": 3.56, "optic neuritis": 11.85, "oral herpes": 7.31, "organising pneumonia": 3.88, "oropharyngeal discomfort": 2.04, "oropharyngeal pain": 2.15, "osteomyelitis": 3.61, "papilloma viral infection": 6.88, "peroneal nerve palsy": 10.88, "pneumonia": 2.6, "pneumonia bacterial": 2.35, "pneumonitis": 2.66, "primary progressive multiple sclerosis": 215.06, "progressive multifocal leukoencephalopathy": 21.67, "progressive multiple sclerosis": 72.81, "psoriasis": 3.03, "pyelonephritis": 2.47, "relapsing multiple sclerosis": 674.6, "relapsing-remitting multiple sclerosis": 37.07, "respiratory tract infection": 3.6, "sars-cov-2 antibody test negative": 33.59, "sars-cov-2 test positive": 3.52, "secondary progressive multiple sclerosis": 80.21, "sensory disturbance": 2.65, "sensory loss": 2.03, "sepsis": 2.85, "sinusitis": 3.03, "skin infection": 3.1, "skin laceration": 2.19, "squamous cell carcinoma": 2.2, "t-lymphocyte count decreased": 52.79, "temperature intolerance": 3.37, "therapeutic response shortened": 9.57, "throat irritation": 9.64, "throat tightness": 2.48, "trigeminal neuralgia": 2.87, "tuberculosis": 2.25, "upper respiratory tract infection": 5.56, "urinary incontinence": 2.83, "urinary tract infection": 8.84, "urosepsis": 14.22, "vulvovaginal mycotic infection": 3.23}